Skip to content
Open access

A Genetic Atlas of Direct and Inverse Neuropsychiatric-Cancer Comorbidity

Jul 2026 · bioRxiv · 0 citations · 99 references
Biology

TL;DR

The findings provide a genome-scale genetic framework for neuropsychiatric–cancer comorbidity and identify shared inherited biological programs as candidates for mechanistic investigation and therapeutic translation.

Abstract

Direct and inverse comorbidities between neuropsychiatric disorders and cancer are increasingly recognised as important features of the nervous system–cancer relationship, yet the inherited genetic architecture underlying these patterns remains poorly understood. Here, we analysed pairwise genetic correlations across 35 diseases represented by 115 GWAS datasets, including 9 psychiatric disorders, 10 neurological diseases and 16 cancers, using linkage disequilibrium score regression (LDSC) and high-definition likelihood (HDL), complemented by meta-analysis, subtype-resolved analyses, local covariance mapping and multi-omic benchmarking. Genetic correlations were predominantly positive and strongest within disease categories, whereas cancer–neurological pairs showed the weakest overall genetic affinity. Meta-analysis and subtype resolution uncovered associations obscured in aggregate analyses, including opposing correlations between familial and late-onset Alzheimer’s disease and lung cancer, revealing subtype-dependent neuro-oncological biology. Local analyses identified recurrent genomic loci where direct comorbidities are consistent with shared inflammatory, interferon, survival and tissue-remodelling programs, whereas inverse comorbidities suggest competing demands on apoptotic regulation, immune tone and stress-response calibration between neuronal and tumour-cell states. Together, these findings provide a genome-scale genetic framework for neuropsychiatric–cancer comorbidity and identify shared inherited biological programs as candidates for mechanistic investigation and therapeutic translation.

Read PDF

Similar papers

Open access Sep 2026

Elucidating shared genetic signals between type 2 diabetes and three neurodegenerative dementia phenotypes

These findings identify shared genetic loci between T2D and neurodegenerative dementia, revealing systemic metabolic-neurodegenerative trade-offs and highlighting key genes that underpin the comorbidity, providing a framework for improved understanding of age-related multi-morbidity.

A. Arruda, Archit Singh, O. Bocher et al. · 0 citations
Open access Jul 2026

Migraine immune cell gene targets and their relationship to psychiatric disorders

It is suggested that immune cell–specific genes, particularly HLA-A, CDK2AP1, and TTC24, may bridge migraine and psychiatric disorders, offering potential candidates for further investigation into shared immunogenetic mechanisms.

X. Mo, Dong-Ren Sun, Fang-Fang Li et al. · 1 citation
Jul 2026

Genetically informed dissection of multimodal brain aging and ten major psychiatric disorders.

The findings reveal partial genetic overlap between altered brain aging and diverse psychiatric disorders, providing an integrative cross-modality perspective on the shared genetic influences and related biological pathways linking brain aging and psychiatric vulnerability.

Qi-Yu Zhao, Qi An, Wen-Jie Cai et al. · 2 citations
Jul 2026

A genome-wide cross-trait analysis characterises the shared genetic architecture between rheumatoid arthritis and psychiatric disorders.

The shared genetic architecture between rheumatoid arthritis and psychiatric disorders is elucidated, providing novel insights into the pathological mechanisms underlying their comorbidity and laying groundwork for improved comorbidity management.

Xin Ke, Shi Yao, Xi Zheng et al. · 0 citations
Open access Sep 2026

Multilevel genomic, transcriptomic, and epidemiologic evidence linking diabetic retinopathy to Alzheimer disease

Genetic liability to DR is associated with an increased risk of AD and is accompanied by shared expression-mediated effects and convergent neurovascular-metabolic pathways, which support the possibility that DR may serve as a clinically accessible indicator of increased neurodegenerative vulnerability.

Jing Li, Qian Liu, Qian Ma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.